Recent News
- Jan 20, 2021
A Medicare claims analysis of rheumatoid arthritis (RA) patients showed that RA-associated interstitial lung disease (RA-ILD) was seen in nearly 5% of patients and was found to increase mortality risks, including respiratory and cancer mortality not explained by other factors.

Links:
Dr. John Cush @RheumNow ( View Tweet)


Dr Philip Robinson @philipcrobinson ( View Tweet)



Dr. John Cush @RheumNow ( View Tweet)



Dr. John Cush @RheumNow ( View Tweet)

Links:
Low Risk of TB with Secukinumab
JAMA Dermatology has reported on a longitudinal cohort study of 12,319 secukinumab (SEC) treated patients (psoriasis, psoriatic arthritis, or ankylosing spondylitis); no new cases of active tuberculosis (TB) and very few cases of latent tuberculosis infection (LTBI) were found.
Read Article
Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:

Links:

Dr. John Cush @RheumNow ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:
Dr. John Cush @RheumNow ( View Tweet)

Links:
Factors Predictive of SLE Flare After HCQ Taper/Discontinuation
The benefits of hydroxychloroquine in lupus are many, but if you were to withdraw HCQ? A recent study of five Canadian cohorts, suggests that certain baseline variables, including age, race, and steroid use, were predictive of flare in patients with SLE who tapered or discontinued treatment with hydroxychloroquine.
Read Article
Links: